Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 3, 2013, Pages 565-575

  Zhang, Yizhou ^a,b   Takahashi, Shoichi ^a,b   Tasaka, Akiko ^a,b   Yoshima, Tadahiko ^c   Ochi, Hidenori ^a,b,c   Chayama, Kazuaki ^a,b,c  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c Institute of Physical and Chemical Research   (Japan)

Author keywords

Apoptosis; Hepatocellular carcinoma; Migration; MiR 224; Proliferation

Indexed keywords

COMPLEMENTARY DNA; MICRORNA; MICRORNA 224; MITOGEN ACTIVATED PROTEIN KINASE 1; P21 ACTIVATED KINASE 2; PROTEIN BCL 2; PROTEIN CDC42; UNCLASSIFIED DRUG; UVOMORULIN;

APOPTOSIS; ARTICLE; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84874363544     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07271.x     Document Type: Article

References (38)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001; 94: 153-156.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 1999; 340: 745-750.
3. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann. Intern. Med. 2003; 139: 817-823.
4. Farazi PA, De Pinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 2006; 6: 674-687.
5. van Hengel J, D'Hooge P, Hooghe B etal. Continuous cell injury promotes hepatic tumorigenesis in CDC42-deficient mouse liver. Gastroenterology 2008; 134: 781-792.
6. Sterpetti P, Marucci L, Candelaresi C etal. Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals. Am. J. Physiol. Gastrointest. Liver Physiol. 2006; 290: G624-632.
7. Takehara T, Liu X, Fujimoto J, Friedman SL, Takahashi H. Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology 2001; 34: 55-61.
8. Hui L, Zatloukal K, Scheuch H, Stepniak E, Wagner EF. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J. Clin. Invest. 2008; 118: 3943-3953.
9. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
10. Lim LP, Lau NC, Garrett-Engele P etal. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773. Epub 2005 Jan 30.
11. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA. Short RNAs repress translation after initiation in mammalian cells. Mol. Cell 2006; 21: 533-542.
12. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
13. Miska EA. How microRNAs control cell division, differentiation and death. Curr. Opin. Genet. Dev. 2005; 15: 563-568.
14. Lu M, Zhang Q, Deng M etal. An analysis of human microRNA and disease associations. PLoS ONE 2008; 3: e3420.
15. Eulalio A, Huntzinger E, Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 2008; 132: 9-14.
16. Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun. 2008; 375: 315-320.
17. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-658.
18. Siegrist F, Singer T, Certa U. MicroRNA expression profiling by bead array technology in human tumor cell lines treated with interferon-alpha-2a. Biol. Proced. Online 2009; 11: 113-129.
19. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 2012; 4: 143-159.
20. Gokhale A, Kunder R, Goel A etal. Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. J. Cancer Res. Ther. 2010; 6: 521-529.
21. Radojicic J, Zaravinos A, Vrekoussis T, Kafousi M, Spandidos DA, Stathopoulos EN. MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle 2011; 10: 507-517. Epub 2011 Feb 1.
22. Yao Y, Suo AL, Li ZF etal. MicroRNA profiling of human gastric cancer. Mol. Med. Report. 2009; 2: 963-970.
23. Bail S, Swerdel M, Liu H etal. Differential regulation of microRNA stability. RNA 2010; 16: 1032-1039.
24. Melendez J, Grogg M, Zheng Y. Signaling role of CDC42 in regulating mammalian physiology. J. Biol. Chem. 2011; 286: 2375-2381.
25. Uemura T, Oda H, Kraut R, Hayashi S, Kotaoka Y, Takeichi M. Zygotic Drosophila E-cadherin expression is required for processes of dynamic epithelial cell rearrangement in the Drosophila embryo. Genes Dev. 1996; 10: 659-671.
26. Li T, Zhang J, Zhu F etal. P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation. Carcinogenesis 2011; 32: 659-666.
27. Kirkin V, Joos S, Zörnig M. The role of Bcl-2 family members in tumorigenesis. Biochim. Biophys. Acta 2004; 1644: 229-249.
28. Shima Y, Nakao K, Nakashima T etal. Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells. Hepatology 1999; 30: 1215-1222.
29. Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J. 2004; 23: 1739-1748.
30. Huang S, He X. The role of microRNAs in liver cancer progression. Br. J. Cancer 2011; 104: 235-240.
31. Weifeng T, Feng S, Xiangji L etal. Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells. Phytomedicine 2011; 18: 158-162.
32. Du D, Pedersen E, Wang Z etal. Cdc42 is crucial for the maturation of primordial cell junctions in keratinocytes independent of Rac1. Exp. Cell Res. 2009; 315: 1480-1489.
33. Mitsushima M, Toyoshima F, Nishida E. Dual role of Cdc42 in spindle orientation control of adherent cells. Mol. Cell. Biol. 2009; 29: 2816-2827.
34. Li Q, Wang G, Shan JL etal. MicroRNA-224 is up-regulated in HepG2 cells and involved in cellular migration and invasion. J. Gastroenterol. Hepatol. 2010; 25: 164-171.
35. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007; 318: 1931-1934.
36. Ma F, Liu X, Li D etal. MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation. J. Immunol. 2010; 184: 6053-6059.
37. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
38. Wang Y, Lee AT, Ma JZ etal. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 upregulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J. Biol. Chem. 2008; 283: 13205-13215. Epub 2008 Mar 4.